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Neurotensin (NT) is an endogenous neuropeptide that exerts potent opioid-independent
analgesic effects, most likely via the type 2 NT receptor (NTR2). Previous morphological
and electrophysiological studies suggested that the NT-NTR2 system is primarily
localized in structures that constitute the descending pain control pathway, such as the
periaqueductal gray (PAG), the rostral ventromedial medulla (RVM), and the spinal dorsal
horn (SDH). However, relevant morphological evidence for this neurotensinergic (NTergic)
circuit is lacking. Thus, the aim of the present study was to morphologically elucidate
the potential sites and connections in the NT-NTR2 system that are involved in the
descending pain control pathway. Based on light and electron microscopy combined with
anterograde and retrograde tracing, we found evidence that NTR2-immunoreactive (IR)
neurons in the RVM receive NT-IR projections originating from the PAG; express NT,
serotonin (5-HT), or both; and send projections that terminate in laminae I and II of the
SDH. These results suggest that NTR2 may contribute to pain control by binding to NT in
the PAG-RVM-SDH pathway. In conclusion, our data provide morphological evidence for an
NTergic PAG-RVM-SDH pathway, implicating novel mechanisms of NT-induced analgesia.
Keywords: neurotensin, NTR2, periaqueductal gray matter, rostral ventromedial medulla (RVM), nociception,
analgesia
INTRODUCTION
Pain is most likely one of the most prevalent human health
problems, contributing to individual morbidity and mortality and
imposing high societal costs (Mogil, 2013). However, due to their
limited efficacy and large numbers of side effects, the current
analgesics for pain remain far from optimal. The most common
reason for these limitations is that the mechanisms underlying
the modulation of nociception in the central nervous system
(CNS) remain poorly understood. Elucidating the nerve fiber
connections and their chemical properties will be beneficial for
determining these pain modulation mechanisms.
The periaqueductal gray (PAG) modulates nociception via
a descending pathway that relays in the rostral ventromedial
medulla (RVM) and terminates in superficial laminae (lami-
nae I and II) of the spinal dorsal horn (SDH; Morgan et al.,
2008), referred to as the PAG-RVM-SDH pathway. This pathway
comprises an essential neural circuit that exerts powerful mod-
ulatory influences on pain (Basbaum and Fields, 1984). Based
on morphological, behavioral, and electrophysiological evidence,
various neurotransmitters, such as GABA and serotonin (5-HT),
are involved in this pathway, thereby contributing to analgesia
under both physiological and pathological conditions (Yang et al.,
2002; Taylor and Basbaum, 2003; Buhler et al., 2005; Morgan
et al., 2008; Mitchell et al., 2009). However, the roles of other
neurotransmitters, including neurotensin (NT), are not fully sup-
ported by these experimental data.
NT is a tridecapeptide that was originally isolated from the
bovine hypothalamus in 1973 (Carraway and Leeman, 1973).
In the CNS, NT exerts many potent effects, including analge-
sia, hypothermia, dopaminergic neurotransmission regulation,
anterior pituitary hormone secretion stimulation, and cancer
cell growth promotion (White et al., 2012). NT and its analogs
exerted dose-dependent analgesic effects in both somatic and
visceral pain paradigms (Dobner, 2006). To date, three subtypes
of NT receptors (NTRs) have been identified. Both NTR1 and
NTR2 are G-protein-coupled receptors that mediate NT-induced
signal transduction (Vincent et al., 1999; Mazella and Vincent,
2006). NTR3 is a single transmembrane receptor that shares 100%
homology with the sorting protein gp95/sortilin, and its function
is unknown (Mazella, 2001).
Previous neuropharmacology studies have demonstrated that
the analgesic effects of NT are primarily mediated by NTR1
and NTR2 (Dubuc et al., 1994; Gully et al., 1997; Pettibone
et al., 2002; Remaury et al., 2002; Dobner, 2006; Buhler
et al., 2008). It has been previously reported that NTR1
expressed by spinally projecting serotonergic neurons in the RVM
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partially contributed to the descending inhibitory modulation of
NT-induced antinociception (Buhler et al., 2005). However,
other lines of evidence suggest that NTR2 is also impli-
cated in NT-mediated analgesia, but its role has not yet been
directly or morphologically elucidated. The analgesic effects
produced by intracerebroventricular administration of NT are
not inhibited by the NTR1-specific antagonist SR48692 but
are blocked by SR142948A, which recognizes both NTR1 and
NTR2 (Gully et al., 1993, 1997; Dubuc et al., 1994; Buhler
et al., 2008). Additionally, receptor knock-down strategies uti-
lizing antisense oligonucleotides also suggest a role of NTR2
in antinociception (Dubuc et al., 1999; Maeno et al., 2004).
However, it remains unclear how these NT-NTR2 interactions
contribute to NT-mediated analgesia. Moreover, our previous
study and other studies suggest that 5-HT, which is strongly
expressed in descending projections from the RVM, acts as
a neurotransmitter that regulates nociceptive transmission in
the superficial laminae of the SDH (Li et al., 2002a; Buhler
et al., 2005). Therefore, based on these previous findings, we
hypothesized that NT may participate in antinociception via a
pathway in which NT released from NT-containing terminals
of neurons originating from the PAG regulates the activities of
NTergic and/or serotonergic spinally projecting neurons by
binding to NTR2 on these RVM neurons, modulating neurotrans-
mitter release in the SDH.
Accordingly, to examine the detailed morphological bases of
our hypothesis regarding the RVM-PAG-SDH pathway, we per-
formed the current study to search for morphological evidence of
this pathway via both light and electron microscopy.
METHODS
ANIMALS
A total of 36 adult male Sprague-Dawley (SD) rats (weighing 250–
300 g) were used in the present study. The Ethics Committee for
Animal Experiments of the Fourth Military Medical University
(Xi’an, P. R. China) approved all animal experiments (Permit
number: 10071). Efforts were made to minimize the number and
suffering of the animals used.
GROUPS
In the present study, rats were randomly separated into three
groups for different purposes. In group 1, the anterograde tracer
biotinylated dextran amine (BDA) was injected into the PAG and
the retrograde tracer fluoro-gold (FG) was injected into the SDH,
followed by immunofluorescence histochemical staining to reveal
the distributions of the RVM-projecting fibers originating from
the PAG, the SDH-projecting neurons located in the RVM, and
the connections between the PAG-originating NTergic fibers and
the SDH-projecting NTR2-immunoreactive (IR) neurons in the
RVM. In group 2, the anterograde tracer BDA was injected into
the PAG and the retrograde tracer horseradish peroxidase (HRP)
was injected into the SDH, followed by electron microscopy
analysis to further determine whether the connections between
the neurons noted form actual synapses. In group 3, after injec-
tion of the retrograde tracer FG into the SDH, colchicine was
administered to the animals, followed by immunofluorescence
histochemical staining to identify the neurochemical properties
of the SDH-projecting neurons in the RVM.
ANTEROGRADE AND RETROGRADE TRACER INJECTION
BDA injection. In the first two groups, the anterograde tracer BDA
was used to identify the RVM-projecting fibers and terminals
originating from the PAG. The procedures for BDA injection
were essentially the same as those previously described by our
group (Niu et al., 2009). Briefly, 0.2 µl of 10% BDA (molecular
weight 10,000 Da; Molecular Probes, Eugene, OR, USA) dissolved
in 0.9% saline was stereotaxically pressure-injected into the right
lateral PAG (LPAG) (8.0 mm posterior to bregma, 0.85 mm
lateral to the midline, and 5.4 mm deep into the cerebral surface)
according to the rat brain atlas (Paxinos and Watson, 2005).
FG/HRP injection. For light microscopy analysis of groups 1
and 3, FG was used as a retrograde tracer to label the neurons
that send projections to the SDH, whereas HRP served as an
appropriate retrograde tracer for electron microscopy analysis of
group 2. The procedures for FG/HRP injection were identical to
those used in our previous studies (Yang et al., 2002; Lü et al.,
2009; Dong et al., 2011). Briefly, for light microscopy analysis
of group 1, after exposing the cervical cord, 0.1 µl of 4% FG
(Fluorochrome, Denver, CO, USA) dissolved in 0.9% saline was
stereotaxically pressure-injected into the right side of the cervical
dorsal horn immediately after BDA injection. In group 3, a similar
procedure for a single FG injection into the SDH was performed
as in group 1. For electron microscopy analysis in group 2, 3 days
after BDA injection, the rats were re-anesthetized and injected
with 0.1–0.3 µl of 30% HRP (Toyobo, Osaka, Japan) dissolved in
0.9% saline into the right side of the cervical dorsal horn.
An adequate survival period was established to allow for the
transportation of the tracers. The rats in groups 1 and 3 were
allowed to recover for 6 days before perfusion, whereas the rats
in group 2 were allowed to recover for 3 days after the injection of
HRP.
COLCHICINE TREATMENT
The rats in group 3 that had previously received a single FG injec-
tion into the SDH were placed in the stereotaxic instrument again,
and 5 µl of colchicine (10 µg/µl; Sigma, St. Louis, MO, USA)
was injected into the lateral ventricle 2 days before perfusion. The
purpose of intracerebroventricular administration of colchicine
was to effectively block axoplasmic transport of the CNS neurons,
thereby markedly increasing the somatic retention of neuropep-
tides, such as NT (Tsukahara and Yamanouchi, 2003). Therefore,
the NT-IR neurons in the RVM, rather than the corresponding
fibers and terminals, were examined.
IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENCE LABELING
AND ANALYSES
The rats in groups 1 and 3 were transcardially perfused with 150
ml of 0.9% saline, followed by 500 ml of 4% paraformaldehyde
in 0.1 M phosphate buffer (PB, pH 7.4). The brains and/or
spinal cords were transversely sliced into 30-µm-thick coronal
sections using a freezing microtome (CM1950, Leica, Heidelberg,
Germany), and the sections were serially collected into six dishes
containing 0.01 M phosphate-buffered saline (PBS, pH 7.4) as six
sets of every sixth serial section.
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The sections in the first dish for both groups (groups 1 and 3)
were used to evaluate the FG injection sites in the SDH and the
distribution patterns of the retrogradely FG-labeled neurons in
the RVM under an epifluorescence microscope (BX-60; Olympus,
Tokyo, Japan) using an appropriate filter for FG (excitation 350–
395 nm; emission 430 nm). Then, these sections were processed
for Nissl staining.
To examine the BDA injection site and the distribution of
anterogradely BDA-labeled fibers and terminals, the sections in
the second dish of group 1 were treated with an Avidin/Biotin Kit
(1:200, SP-2001; Vector Labs, Burlingame, CA, USA). Then, BDA
was visualized using the chromogen diaminobenzidine (DAB).
Finally, the sections were observed under a light microscope (AH-
3; Olympus, Tokyo, Japan).
The sections in the third, fourth, and fifth dishes of group
1 were used to evaluate the triple-labeling of FG/NTR2/BDA,
FG/NT/BDA, and NTR2/NT/BDA, respectively. All of the antisera
used in this study are presented in Table 1. The sections were
incubated at room temperature in primary antisera in 0.01 M PBS
containing 5% normal donkey serum (NDS), 0.3% Triton X-100,
0.05% NaN3, and 0.25% carrageenan (PBS-NDS, pH 7.4) for 24
h. Then, the sections were incubated in fluorescein-labeled IgG
(second antisera) for 6 h.
The sections in the second and third dishes of group 3 were
processed for triple-labeling of FG/NT/NTR2 and NTR2/NT/5-
HT, respectively. Different antisera (Table 1) were used for
triple-immunofluorescence histochemical staining. Similarly, the
sections were sequentially incubated at room temperature in
primary antisera for 24 h and the secondary antisera for 6
h, followed by incubation in fluorophore-conjugated avidin
D for 2 h.
The sections in the sixth dish were used for control experi-
ments. The procedures were the same as those described above
except that the primary antisera were omitted or were replaced
Table 1 | Antisera used in each group.
Methods Purpose Primary antiserum Secondary antiserum Tertiary antiserum
Light microscopy NTR2/BDA/FG Rabbit anti-NTR2 (1:1000,
Millipore, Temecula, CA, USA)
Guinea pig anti-FG (1:100,
Protos Biotech, New York, NY,
USA)
Alexa594 donkey anti-rabbit
(1:500, Invitrogen, Camarillo,
CA, USA) Alexa488 goat
anti- guinea pig (1:500,
Invitrogen) Alexa647 avidin
(1:1000, Invitrogen)
FG/BDA/NT Guinea pig anti-FG (1:100, Protos
Biotech) Rat anti-NT (1:200, Protos
Biotech)
Alexa488 goat anti-guinea pig
(1:500, Invitrogen) Alexa594
goat anti-rat (1:500,
Invitrogen) Alexa647 avidin
(1:1000, Invitrogen)
NTR2/BDA/NT Rabbit anti-NTR2 (1:1000,
Millipore) Rat anti-NT (1:200,
Protos Biotech)
Alexa488 donkey anti-rabbit
(1:500, Invitrogen) Alexa594
goat anti- rat (1:500,
Invitrogen) Alexa647 avidin
(1:1000, Invitrogen)
NTR2/NT/FG Rabbit anti-NTR2 (1:1000,
Millipore) Rat anti-NT (1:200,
Protos Biotech) Guinea pig anti-FG
(1:100, Protos Biotech)
Biotinylated donkey
anti-rabbit (1:500, Millipore)
Alexa594 goat
anti-rat (1:500, Invitrogen)
Alexa488 goat anti-guinea pig
(1:500, Invitrogen)
Alexa647 avidin
(1:1000, Invitrogen)
NTR2/NT/5-HT Rabbit anti-NTR2 (1:1000,
Millipore) Rat anti-NT (1:200,
Protos Biotech) Goat anti-5-HT
(1:500, Immunostar, Hudson, WI,
USA)
Biotinylated donkey
anti-rabbit (1:500, Millipore)
Cy3 donkey anti-rat (1:500,
Millipore) Alexa647 donkey
anti-goat (1:500, Invitrogen)
FITC-avidin (1:1000, Vector
Labs)
Electron microscopy NT/NTR2/HRP* Rabbit anti-NTR2 (1:1000,
Millipore) Rat anti-NT (1:200,
Protos Biotech)
Biotinylated donkey anti-Rat
IgG (1:200, Millipore) Goat
anti-rabbit IgG conjugated to
1.4-nm gold particles (1:100;
Nanoprobes)
Avidin-biotinylated
peroxidase complex
(1:50, Vector Labs)
NTR2/BDA/HRP* Rabbit anti-NTR2 (1:1000,
Millipore)
Goat anti-rabbit IgG
conjugated to 1.4-nm gold
particles (1:100; Nanoprobes)
Avidin-biotinylated peroxidase
complex (1:50, Vector Labs)
NT/BDA/HRP* Rat anti-NT (1:200, Protos Biotech) Goat anti-rat IgG conjugated
to 1.4-nm gold particles
(1:100; Nanoprobes)
Avidin-biotinylated peroxidase
complex (1:50, Vector Labs)
∗The DAB reaction utilized for the demonstration of HRP in each group was performed before the immuno-electron microscopy procedures.
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with normal serum from the same species. No immunopositive
products were detected.
After immunofluorescence histochemical staining, the sec-
tions were observed and images were captured under a confocal
laser-scanning microscope (CLSM, FV1000, Olympus, Tokyo,
Japan). Digital images were captured using FLUOVIEW software
(Olympus).
For immunofluorescence histochemical staining analysis of
NTR2/NT/FG in the RVM, the neurons were counted to esti-
mate the co-localization of the markers. Seven transverse sections
selected from each animal were analyzed to provide an adequate
sample size and to ensure that the entire RVM was examined. The
sections were selected at the following distances caudal to bregma
(Paxinos and Watson, 2005): 11.4, 11.16, 10.92, 10.68, 10.44,
10.2, and 9.96 mm. Neuronal counting rather than stereological
methods were used, providing potentially biased estimates of
the total number of neurons in each group. Counting of all
labeled profiles that were present in each section was performed
to determine the number of labeled profiles that contained NTR2,
NT, or FG. The analyzed sections were separated by 200–300
µm to minimize the possibility of counting the same cell more
than once.
ELECTRON MICROSCOPY ANALYSIS
In group 2, the rats recovered for 3 days after BDA injection
into the PAG, followed by recovery for an additional 3 days after
HRP injection into the cervical spinal cord. The rats were deeply
anesthetized and then transcardially perfused with 0.9% saline,
followed by 0.1 M PB containing 4% paraformaldehyde, 0.05%
glutaraldehyde, and 0.2% picric acid.
Transverse sections from the midbrain to the cervical cord
were generated using a vibratome (Microslicer DTM-1000, DSK,
Kyoto, Japan) at a 50-µm thickness and were serially collected into
four dishes. All sections in the four dishes were processed for the
histochemical detection of HRP using the tetramethylbenzidine-
sodium tungstate (TMB-ST) method (Gu et al., 1992). The
HRP reaction products were intensified using a DAB/cobalt/H2O2
solution (Rye et al., 1984). The sections in the first dish were
mounted on gelatin-coated slides and were used to observe the
HRP injection sites in the spinal cord.
The reacted sections of the lower medulla oblongata from
the second, third, and fourth dishes were freeze-thawed in liquid
nitrogen to enhance the penetration of the antibodies. Details of
the immuno-electron microscopy procedures were described in
our previous reports (Li et al., 2002b). Briefly, the sections were
incubated in 20% Tris-buffered saline (TBS)-NDS for 1 h to block
non-specific immunoreactivity. The sections in the second, third,
and fourth dishes were incubated for 24 h at 4◦C in primary anti-
bodies to NT/NTR2, NTR2, and NT (Table 1), respectively. Then,
the second, third, and fourth dishes were incubated overnight in
biotinylated donkey anti-rat IgG/goat anti-rabbit IgG conjugated
to 1.4-nm gold particles for NTR2, goat anti-rabbit IgG
conjugated to 1.4-nm gold particles for NTR2, or goat anti-rat IgG
conjugated to 1.4-nm gold particles for NT (Table 1), respectively,
at 48◦C. Subsequently, all sections were processed according to the
following steps: (1) post-fixation with glutaraldehyde, (2) silver
enhancement using the HQ Silver Kit (Nanoprobes, Stony Brook,
NY, USA), (3) incubation with the ABC kit (Vector), (4) reaction
with DAB tetrahydrochloride and H2O2, (5) osmification; and
(6) counterstaining with uranyl acetate. Ultrathin sections at a
70-nm thickness were prepared from the superficial laminae of
the SDH, mounted on single-slot grids, and examined under an
electron microscope (JEM1440, Tokyo, Japan).
RESULTS
LIGHT MICROSCOPY ANALYSIS
Distribution of the BDA-labeled fibers and the FG-labeled neurons
in the RVM
For immunofluorescence labeling analysis of groups 1 and 3, the
anterograde tracer BDA was injected into the PAG (Figures 1A,C)
and the retrograde tracer FG was injected into the cervical SDH
(Figures 1B,D). The BDA-labeled fibers and axon terminals were
widely scattered from the rostral to the caudal ventral portion of
the brainstem, including a dense distribution in the RVM, espe-
cially within the nucleus raphe magnus (NRM). Injections of FG
into the right cervical SDH resulted in many retrogradely labeled
spinally projecting neurons in the RVM (results not shown).
PAG efferents projecting to the RVM contact spinally projecting
NTR2-IR neurons
The anterogradely labeled fibers and terminals originating
from the PAG contacted the retrogradely FG-labeled spinally-
projecting neurons in the RVM (Figure 2). Although BDA
was injected into a relatively limited portion of the PAG, the
BDA-labeled fibers and terminals were found in close apposition
to approximately 32% (80/248) of the FG-labeled spinally pro-
jecting neurons that were analyzed. Moreover, 59% (146/248)
FIGURE 1 | Bright-field and fluorescence photomicrographs showing
the BDA injection site in the LPAG (A, scale bar = 100 µm) and the FG
injection site in the cervical SDH (B, scale bar = 200 µm). Camera lucida
drawings show the rostro-caudal extent of the BDA (C) and FG (D) injection
sites at different levels, indicated by the blackened areas on the drawings.
The numbers (C) correspond to the distance in millimeters (mm) posterior
to bregma in the brain, and C3, C5, and C7 (D) indicate the corresponding
segments of the cervical spinal cord. Aq: aqueduct; DR: dorsal raphe
nucleus; DH: dorsal horn; VH: ventral horn; CC: central canal.
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of the retrogradely labeled spinally projecting neurons displayed
NTR2-IR staining (Figure 2A). The BDA-labeled fibers and
terminals in the RVM often targeted these NTR2-IR neurons
(Figure 2A). Specifically, 51 of the 80 spinally projecting neurons
(63%) that were apposed to PAG fibers also displayed NTR2
immunoreactivity.
NTergic fibers and terminals from the PAG target NT-IR spinally
projecting neurons in the RVM
Many of the PAG efferent fibers projecting to the RVM displayed
NT immunoreactivity (Figure 2B). These NTergic fibers and
terminals from the PAG frequently targeted FG-labeled neurons
in the RVM. In the current study, approximately half (51%) of the
fibers and terminals from the PAG contacted FG-labeled spinally
projecting neurons that also displayed NT immunoreactivity. In
contrast, of the 80 PAG efferent fibers that targeted FG-labeled
cells, 39 (49%) did not display NT immunoreactivity.
NTergic fibers and terminals from the PAG contact NTR2-IR neurons
in the RVM
The BDA-labeled fibers and terminals were often found to con-
tact NTR2-IR neurons in the RVM (Figure 2C). A total of 93
BDA-labeled axon terminals were found in close apposition to
253 NTR2-IR neurons; 43% (40/93) of these BDA-labeled axon
terminals displayed NT immunoreactivity.
Spinally projecting NTR2-IR neurons display NT immunoreactivity
in the RVM
In group 3, triple-labeling immunofluorescence histochemical
staining was conducted to determine the exact neurochemical
properties of the FG-labeled neurons on which NTR2 is
expressed. It has been reported that NTR1 is expressed almost
exclusively on serotonergic neurons in the RVM, approximately
50% of which project directly to the dorsal horn of the spinal
cord (Buhler et al., 2005). Therefore, in this study, we primar-
ily focused on the neurochemical properties of the NTR2-IR
RVM neurons. After colchicine treatment, the neuropeptide NT
is largely retained in the somata of the RVM neurons. Taking
advantage of this method, we found that 80.65% of the NTR2-
IR neurons in the RVM were also immunoreactive for NT-IR.
Of these NT/NTR2 double-labeled neurons, approximately half
(47.54%) were labeled with FG injected into the cervical dorsal
horn (Figure 3).
NTR2-IR RVM neurons express both NT and 5-HT
Because serotonergic neurons were previously demonstrated to be
involved in the descending pain control pathway, especially those
localized in the RVM, we further investigated the relationship
between NT and 5-HT expression and whether the NTR2-IR
RVM neurons also express 5-HT. Our triple-labeling immunoflu-
orescence histochemical staining results suggested that the NTR2-
IR RVM neurons express both NT and 5-HT. Specifically,
FIGURE 2 | Representative fluorescence photomicrographs displaying the
close contacts between anterogradely BDA-labeled fibers and terminals
and FG/NTR2 double-labeled neurons (A), between BDA-labeled NTergic
fibers and terminals and retrogradely FG-labeled neurons (B), and
between BDA-labeled NTergic fibers and terminals and NTR2-IR neurons
(C). The white arrowheads indicate the locations of the BDA-labeled and/or
NT-IR terminals and fibers in close contact with FG-labeled, NT/FG co-labeled,
or NTR2-IR neuronal somata and dendritic processes. Scale bar = 20 µm.
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FIGURE 3 | Representative fluorescence photomicrographs showing
FG- (A, green), NT- (B, red), and NTR2- (C, blue) triple-labeled
neurons in the RVM. The images from (A–C) are merged in (D). The
rectangular areas in (A–D) were enlarged and displayed in (A’–D’). The
arrows indicate NTR2/NT double-labeled neurons; the unfilled
arrowheads indicate NTR2-IR neurons; and the filled arrowheads indicate
FG/NT/NTR2 triple-labeled neurons in the RVM (D’). Scale bar = 80 µm
(A–D) or 30 µm (A’–D’). (E) The mean number of NTR2-IR or NTR2/NT
double-labeled or NTR2/NT/FG triple-labeled neurons in the RVM at
seven rostro-caudal levels (from 11.4 mm to 9.96 mm caudal to bregma)
revealed via immunofluorescence histochemical triple-staining for NTR2,
NT, and FG (n = 5 rats).
5-HT immunoreactivity was strongly detected in the neuronal
somata and their processes (Figure 4). Approximately 80.65%
and 45.42% of the NTR2-IR neurons were immunopositive
for NT and 5-HT, respectively. NTR2/NT/5-HT triple-labeled
neurons accounted for 33.43% of all NTR2-IR RVM neurons
(Table 2).
ELECTRON MICROSCOPY ANALYSIS
To generate potent morphological evidence for the connections
observed via light microscopy analysis, electron microscopy anal-
ysis was performed to detect synaptic connections and to elucidate
the neurochemical properties of the synapses on such an NT-
NTR2 participated pathway.
NT-IR terminals form synapses with spinally projecting NTR2-IR
RVM neurons
Triple-staining for NT-IR, NTR2-IR, and HRP was performed
to detect the synaptic connections and neurochemical proper-
ties of the NT-IR synaptic buttons, the NTR2-IR neurons, and
the spinally projecting RVM neurons (Figure 5A). Under elec-
tron microscopy, the HRP-labeled spinally projecting neurons
were detected based on the presence of highly electron-dense
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FIGURE 4 | Representative fluorescence photomicrographs showing
NTR2- (A, green), NT- (B, red), and 5-HT- (C, blue) triple-labeled neurons
in the RVM. The images from (A–C) are merged in (D). The rectangular areas
in (A–D) were enlarged and displayed in (A’–D’). The filled arrowheads
indicate NTR2/NT double-labeled neurons; the unfilled arrowheads indicate
NTR2/5-HT double-labeled neurons; and the arrows indicate NTR2/NT/5-HT
tripe-labeled neurons in the RVM (D’). Scale bar = 80 µm (A–D) or 25 µm
(A’–D’).
clumps of crystalline material and occasionally the presence of
amorphous puncta in the cytoplasm and in large dendrites. NTR2
immunoreactivity was determined based on the presence of the
immunogold-silver grains, which were distributed in the cyto-
plasm, dendrites, and axonal fibers and terminals of the NTR2-
IR neurons. The dendrites or somata containing more than four
immunogold-silver grain particles in their postsynaptic structure
were considered to indicate NTR2-IR neurons. The NT-IR axonal
terminals, typically filled with synaptic vesicles, were character-
ized based on the presence of electron-dense DAB reaction prod-
ucts that adhered to the outer surface of organelles, such as mito-
chondria, synaptic vesicles, and the inner surface of the plasma
membrane. It was found that NT-IR axonal terminals containing
DAB reaction products formed asymmetric synaptic connections
with the dendritic profiles or neuronal somata containing HRP-
labeling products and/or immunogold-silver-enhanced particles
corresponding to NTR2 (Figure 5A).
Table 2 | The number of neurons immunopositive for NTR2, NT,
5-HT, and all three markers in the RVM∗.
Markers
(1) NTR2+ neurons (mean ± S.E.M) 139 ± 5.39
(2) NT+ neurons (mean ± S.E.M) 129 ± 4.98
(3) 5-HT+ neurons (mean ± S.E.M) 149 ± 3.37
(4) NTR2/NT+ neurons (mean ± S.E.M) 114 ± 5.28
(5) NTR2/5-HT+ neurons (mean ± S.E.M) 101 ± 3.91
(6) NTR2/NT/5-HT+ neurons (mean ± S.E.M) 45 ± 2.15
(7) (4)/(1) × 100% 80.65%
(8) (5)/(1) × 100% 45.42%
(9) (6)/(1) × 100% 33.43%
*The counts in rats were performed on six sections from a series of every
fourth 30-µm-thick section.
The BDA-labeled terminals from the PAG formed synapses with
spinally projecting NTR2-IR RVM neurons
Another aim of this EM study was to confirm the synap-
tic connections between the BDA-labeled descending axonal
terminals and the spinally projecting NTR2-IR RVM neurons
using a triple-labeling method (Figure 5B). At the ultrastruc-
tural level, BDA-labeled products, HRP-labeled structures, and
NTR2-IR gold particles enhanced using silver solution dis-
played the same morphological appearance as described above.
Under electron microscopy, it was observed that the BDA-labeled
axonal terminals filled with DAB reaction products formed
asymmetric synapses with dendritic profiles or somata contain-
ing both HRP-labeled products and NTR2-IR gold particles.
These results indicate that the axon terminals from the PAG
formed synaptic contacts with spinally projecting NTR2-IR RVM
neurons.
NT-IR terminals from the PAG formed synapses with spinally
projecting RVM neurons
Moreover, after BDA was injected into the PAG and HRP was
injected into the SDH, under electron microscopy, synaptic
connections were detected between NT-IR terminals originating
from PAG containing both anterogradely BDA-labeled DAB reac-
tion products and NT-IR gold particles and retrogradely HRP-
labeled neuronal somata and dendritic processes in the RVM
(Figure 5C). These results indicate that the BDA/NT double-
labeled terminals originating from the PAG form synapses with
HRP-labeled dendrites or somata that send projecting fibers to
the spinal cord.
DISCUSSION
In the current study, we demonstrated that NTR2-IR RVM
neurons that project to the SDH receive NTergic descending
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FIGURE 5 | Electron photomicrographs showing the synaptic
connections in the RVM revealed using the triple-labeling method. An
NT-IR axon terminal (Ax-NT) (A) or a BDA-labeled axon terminal (Ax-BDA) (B)
synapses on a dendrite that is retrogradely labeled with HRP (Den-HRP) and
immunopositively stained for NTR2. The synaptic contact between an
NT/BDA double-labeled axon terminal (Ax-BDA+NT) and an HRP-labeled
dendritic profile (Den-HRP) is also shown (C). The arrowheads indicate the
post-synaptic membranes. Mit: mitochondria.
FIGURE 6 | Schematic diagram of the proposed NT-NTR2 system in the
PAG-RVM-SDH pathway. The efferent NT-expressing axon terminals from
the PAG synapse on spinally projecting RVM neurons. The NT-expressing
nerve fibers from the PAG may primarily synapse on NTergic neurons in the
RVM that display NTR2-immunopositive staining, which, in turn, project to
the SDH. In addition, some of the NTR2-IR neurons, but relatively fewer
than the NT-IR neurons, express 5-HT. Approximately one-third of these
NTR2-IR neurons appear to utilize both NT and 5-HT as their
neurotransmitters. Thus, NT and 5-HT may be co-released in the SDH to
modulate nociceptive transmission.
projecting fibers and terminals originating from the PAG based
on morphological analysis via tract tracing, immunofluores-
cence and immunohistochemical staining, and light and electron
microscopy. A subset of the neurons projecting from both the PAG
and RVM appear to utilize NT as a neurotransmitter. Further-
more, approximately one-third of the NTR2-IR neurons in the
RVM that sent projection fibers to the spinal cord expressed both
NT and 5-HT. These findings suggest that NT-NTR2-mediated
signaling is involved in an NTergic PAG-RVM-SDH descending
pathway.
Due to the importance of the PAG-RVM-SDH descending
pain control pathway in mammals, many studies have been
performed to elucidate the mechanisms underlying this critical
pathway. Consistent with previous reports (Morgan et al., 2008),
we confirmed that terminals from the PAG synapsed on spinally
projecting RVM neurons. There are many NT-IR neurons in the
PAG, and a major NTergic projection from the PAG to the RVM
contributes to the descending modulation of nociception (Beitz
et al., 1983). In addition, NT-IR neuronal somata and terminals
are detected in the RVM (Dobner, 2006). Previous studies have
also shown that NTR2 mRNA and protein are expressed in the
RVM (Maeno et al., 2004). Our present data integrate all these
independent findings and show that NTR2-IR neurons in the
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RVM receive NT-IR projections originating from the PAG and,
in turn, send projections to the superficial laminae (laminae I
and II) of the SDH. The present results provide morphological
evidence for an NTergic PAG-RVM-SDH descending pathway.
These morphological data are consistent with those of previous
neuropharmacology studies, suggesting that NTR2 in the RVM is
essential for NT-induced analgesia. Microinjection of the selective
NTR2 agonist beta-lactotensin (β-LT) or the non-selective NTR2
agonist levocabastine into the RVM produces antinociception
based on tail-flick tests (Smith et al., 1997; Buhler et al., 2008).
Similarly, NT-induced antinociception is not completely blocked
by the selective NTR1 antagonist SR48692 (Dubuc et al., 1994;
Buhler et al., 2005).
Our present data also show that RVM neurons displaying both
NTR2- and NT-immunopositive labeling send fibers projecting to
the SDH. Specifically, more than 80% of the NTR2-IR neurons
in the RVM were found to express NT, approximately half of
which project to the SDH. These NTergic projections from the
RVM to the SDH may partially account for the NT-IR fibers
and terminals in the spinal cord, which were detected previously
(Seybold and Elde, 1982). The other NT/NTR2-IR neurons that
are not labeled with FG may either contact local circuit neurons
within the RVM, thus regulating NT-mediated signal transduc-
tion, or may represent SDH-projecting neurons that fail to absorb
the tracer. It has been reported that the antinociceptive response
induced by the NTR2 agonist β-LT is reduced via intrathe-
cal administration of yohimbine, an α2-adrenoceptor antagonist
(Buhler et al., 2008), indicating that the effects of NTR2 are
likely partially mediated by noradrenalin release. However, to
our knowledge, there are no noradrenergic neurons present in
the RVM. Tract tracing combined with immunohistochemical
identification of noradrenergic A7 neurons that directly project
to the spinal cord demonstrated that the majority of the neu-
rons in the RVM, including the NRM and the nucleus reticu-
laris gigantocellularis pars α, project to the A7 cell group and
the surrounding area of the dorsolateral pontine tegmentum
(Clark and Proudfit, 1991; Holden and Proudfit, 1998). There-
fore, we propose that the remaining NTR2-IR neurons observed
in our study directly or indirectly project to the noradrenergic
A7 cell group, thereby modulating noradrenalin release in the
spinal cord.
It is well known that 5-HT serves as a primary neurotrans-
mitter for the descending projection from the RVM to the spinal
cord. The present results showed that 5-HT is expressed in NTR2-
IR neurons. Approximately half (45.42%) of the NTR2-IR RVM
neurons displayed 5-HT immunoreactivity, and approximately
one-third (33.43%) of the NTR2/NT-IR neurons expressed 5-
HT. These results indicated that NT and 5-HT are co-expressed
in NTR2-IR neurons in the RVM and, thus, are most likely
co-released simultaneously in the SDH to modulate nociceptive
transmission. Our previous study revealed that 5-HT exerts an
analgesic effect by potentiating glycine release in the superficial
laminae neurons via the protein kinase C pathway (Li et al.,
2002a). The detection of serotonergic neurons that were not
labeled with NTR2 or NT may be due to the following three
reasons. First, they may express NTR1 and account for another
portion of serotonergic neurons in the RVM that descend to
the SDH. Second, the procedures for the tissue treatment or
the processes of triple-labeling immunohistochemistry may also
affect the detectability of the antibodies. Third, not all of the
SDH-projecting serotonergic neurons are modulated by the neu-
rotensinergic system.
Previous studies have indicated that both NTR1 and NTR2
are required for NT-induced antinociception. The results of pre-
vious studies using NTR1 knockout mice have demonstrated
an important role for NTR1 in NT-induced antinociception
based on the hot plate test (Pettibone et al., 2002) but not the
acetic acid-induced writhing test (Remaury et al., 2002). Phar-
macological antagonist and agonist studies provide evidence that
NTR2 is also involved in the analgesic effect of NT. The anal-
gesic effects produced by intracerebroventricular administration
of NT are not attenuated by the NTR1 antagonist SR 48692
but are blocked by SR 142948A, which antagonizes both NTR1
and NTR2 (Dubuc et al., 1994; Gully et al., 1997). Selectively
activating NTR2 via injection of β-LT into the RVM of rats
produces an antinociceptive response based on the tail withdrawal
test (Buhler et al., 2008). In addition, an antisense inhibition
experiment further supported the evidence for the involvement
of NTR2 in NT-induced antinociception. Central administration
of phosphorothioate antisense oligonucleotides against NTR2
clearly inhibited the NT-mediated antinociceptive response based
on the acetic acid-induced writhing test (Dubuc et al., 1999).
Taken together, it appears that both NTR1 and NTR2 are required
for different aspects of NT-induced analgesia, as NTR1 is spe-
cific for hot plate tests and NTR2 is specific for writhing tests.
However, recently, two different lines of evidence have chal-
lenged this sharp distinction between these two receptors.
NT79 and levocabsatine (both NTR2-selective agonists) reduced
writhing in NTR1−/− mice, whereas NT72 (an NTR1-selective
agonist) exerted a significant analgesic effect on NTR2−/−
mice, indicating that both NTR1 and NTR2 are involved in
NT-mediated analgesia in a visceral pain model using acetic
acid-induced writhing tests (Smith et al., 2012). Moreover,
it has been found that both NTR1 and NTR2 suppress the
persistent inflammatory pain responses observed after intra-
plantar injection of formalin into rats (Roussy et al., 2008,
2009).
Combining our current results with the previous findings,
we conclude that an NTergic PAG-RVM-SDH descending path-
way significantly contributes to NT-induced analgesia. Specifi-
cally, convergent stimulation activates NTergic neurons in the
PAG, in turn exciting the spinally projecting NT/NTR2 co-
expressing RVM neurons, which most likely simultaneously
increases NT and 5-HT release in the spinal cord, thereby mod-
ulating pain transmission (Figure 6). In contrast to the NTergic
PAG-RVM descending pathway, the involvement of NTR2 in
the NTergic pathway from the PAG to the SDH most likely
indicates that NTR2 is critical for NT-mediated analgesia. Fur-
thermore, the current study may bridge the analgesic effects
of NT between the spinal and supraspinal levels. Nonetheless,
the present study also has some limitations. Due to the limita-
tions of the immunohistochemical staining method, quadruple
or quintuple staining is not available to simultaneously inves-
tigate all of the relationships and connections described in the
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present study. Moreover, to fully establish the functional role
of and the downstream molecular mechanisms underlying NT
and NTR2 activity in the NT-NTR2 pathway, experiments com-
bining morphology, physiology, and molecular biology must
be performed to determine whether and how these labeled
neurons and terminals function in different circuits at various
levels.
CONCLUSION
There is an indirect NTergic PAG-RVM-SDH descending pathway
from the PAG to the SDH. Both NT and NTR2 are critical for this
pathway. This pathway may represent an important component of
the descending system involved in the modulation of nociceptive
transmission.
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